# Early Prediction of Biliary Atresia Using Combi-Elastography in Infants ≤ 60 Days of Age

**Authors:** Fenglin Xu, Chenpeng Zheng, Caihui Hu, Mingzhu Yu, Xiang Li, Yang Gao, Yi Tang, Jingyu Chen

PMC · DOI: 10.3390/diagnostics16040571 · 2026-02-13

## TL;DR

This study introduces a new model using combi-elastography and lab tests to predict biliary atresia in infants under 60 days old.

## Contribution

The novel predictive model integrates combi-elastography with clinical indicators for early detection of biliary atresia.

## Key findings

- A nomogram model using GGT, gallbladder morphology, and fibrosis index achieved an AUC of 0.887 in predicting biliary atresia.
- The model showed high sensitivity (86.4%) and specificity (76.0%) in differentiating biliary atresia from other cholestatic diseases.

## Abstract

Background: To improve the early recognition of biliary atresia (BA) and timely treatment, this study developed a predictive model integrating combi-elastography, a novel form of elastography, to distinguish biliary atresia from other cholestatic liver diseases (non-BA) in infants. Method: A total of 69 children aged < 60 days with cholestatic hepatitis were retrospectively enrolled. All patients underwent conventional ultrasonography, combi-elastography, and laboratory testing. The variables were selected using logistic regression to construct a nomogram model, and the performance of the model was evaluated. Results: Multifactorial logistic regression analysis indicated that GGT (p = 0.015), the gallbladder morphology (p = 0.017), and the fibrosis index of the combi-elastography (p = 0.017) could be used as independent predictors to differentiate BA from other causes of cholestasis. A nomogram model constructed with these three indexes showed better performance, with an area under the operating characteristic curve (AUC) of 0.887 (0.823, 0.952) (p < 0.001), sensitivity of 86.4%, and specificity of 76.0%. Using 1000 Bootstrap resamples for internal validation of the model, the predictive effect of the nomogram model to identify biliary atresia from other cholestatic liver diseases was in good agreement with the actual situation. Decision-curve analysis showed that the use of the nomogram model to predict biliary atresia gained more clinical value at a risk threshold of 0.10–0.80. Conclusion: The nomogram constructed integrating combi-elastography and liver function indices shows promising value for predicting the risk for developing biliary atresia.

## Linked entities

- **Chemicals:** GGT (PubChem CID 24801861)
- **Diseases:** biliary atresia (MONDO:0008867)

## Full-text entities

- **Genes:** LOC102724197 (inactive glutathione hydrolase 2) [NCBI Gene 102724197] {aka GGT2}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316] {aka MMP-7, MPSL1, PUMP-1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** obesity (MESH:D009765), hepatic steatosis (MESH:D005234), biliary lesions (MESH:D001660), jaundice (MESH:D007565), fever (MESH:D005334), systemic diseases (MESH:D034721), Fibrosis (MESH:D005355), gallbladder (MESH:D005705), injury to (MESH:D014947), inflammation (MESH:D007249), cholestatic liver disease (MESH:D008107), BA (MESH:D001656), Alagille syndrome (MESH:D016738), mental illness (MESH:D001523), renal failure (MESH:D051437), hepatic fibrosis (MESH:D008103), cardiac failure (MESH:D006333), biliary obstruction (MESH:D001658), hepatic failure (MESH:D017093), hepatocellular injury (MESH:D056486), AI (MESH:C566784), ascites (MESH:D001201), portal hypertension (MESH:D006975), viral infections (MESH:D014777), citrin deficiency (MESH:C538053), cholestasis (MESH:D002779), choledochal cysts (MESH:D015529)
- **Chemicals:** Bilirubin (MESH:D001663), CE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939678/full.md

---
Source: https://tomesphere.com/paper/PMC12939678